Catalio Capital Management, LP: 13F holdings
CIK 19581252026Q2
| Positions | 39 |
|---|
| Reported value | $532.1m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 39 (-2 vs prior quarter) |
|---|
| Reported value | $532.1m (+11.2%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| AVALYN PHARMACEUTICALS INC | 1,675,830 | $55.2m | 10.4% |
| JNJ JOHNSON & JOHNSON | 138,946 | $35.3m | 6.6% |
| GILD GILEAD SCIENCES INC | 269,309 | $34.0m | 6.4% |
| BBIO BRIDGEBIO PHARMA INC | 455,041 | $33.9m | 6.4% |
| SNDX SYNDAX PHARMACEUTICALS INC | 1,215,698 | $26.6m | 5.0% |
| DFTX DEFINIUM THERAPEUTICS INC | 562,672 | $26.5m | 5.0% |
| BMY BRISTOL-MYERS SQUIBB CO | 412,961 | $23.8m | 4.5% |
| PBLS PARABILIS MEDICINES INC | 824,043 | $22.6m | 4.2% |
| NTRA NATERA INC | 82,181 | $22.3m | 4.2% |
| INCY INCYTE CORP | 191,627 | $21.7m | 4.1% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1958125")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples